\(
\def\WIPO{World Intellectual Property Organisation}
\)
Sources of Biopharmaceutical Innovation : An Assessment of Intellectual Property.
2015
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Cite
Citation
Files
Détails
Titre
Sources of Biopharmaceutical Innovation : An Assessment of Intellectual Property.
Variante du titre
Economic Research Working Paper No. 24
Auteur
Type d’élément
Working paper
Description
14 pages ; [28] cm.
ISSN
2957-8256
Résumé
An analysis of new, FDA-approved molecular entities reveals dynamism in terms of new innovation. An assessment of the first patent for each drug reveals that the pharmaceutical industry, particularly large, established companies in North America, tend to dominate the field. Whereas inventors continue to found biotechnology companies at a steady rate, recent trends suggest these inventors more often come from the private sector.
Série
Type de fichier
Digital publication.
Série
Economics Working Papers.
Traductions
Publié
Geneva, Switzerland : [World Intellectual Property Organization], 2015.
Langue
Anglais
Le document apparaît dans